Novo wins FDA blessing for Ozempic, a weekly diabetes drug carrying big expectations
admin 5th December 2017 Uncategorised 0Novo’s vaunted Victoza follow-up is here. The FDA on Tuesday approved Ozempic along with diet and exercise to improve glycaemic control in adults with Type 2 diabetes, setting it on a path expected to lead to blockbuster sales.
More: Novo wins FDA blessing for Ozempic, a weekly diabetes drug carrying big expectations
Source: fierce